Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Foà R, Vitale A, Vignetti M, Meloni G, Guarini A, De Propris MS, Elia L, Paoloni F, Fazi P, Cimino G, Nobile F, Ferrara F, Castagnola C, Sica S, Leoni P, Zuffa E, Fozza C, Luppi M, Candoni A, Iacobucci I, Soverini S, Mandelli F, Martinelli G, Baccarani M; GIMEMA Acute Leukemia Working Party.
Blood. 2011 Dec 15;118(25):6521-8. doi: 10.1182/blood-2011-05-351403. Epub 2011 Sep 19.
Acute leukemia.
Ganser A, Hoelzer D.
Curr Opin Hematol. 1994 Jul;1(4):248-55.
Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemia.
Yuan J, Zhang J, Zhao B, Liu F, Liu T, Duan Y, Chen Y, Chen X, Zou Y, Zhang L, Guo Y, Yang W, Yang Y, Wei J, Zhu X, Zhang Y.
Cancer Lett. 2024 Aug 1;596:217018. doi: 10.1016/j.canlet.2024.217018. Epub 2024 Jun 4.
Flow cytometric detection of leukemic blasts in Libyan pediatric patients with acute lymphoblastic leukemia.
Elbnnani AS, Elbasir M, Altabal S, Lamami Y, Ebrahim F, Oshah HM, Alagnef R, Elzagheid A, Abulayha AM.
Libyan J Med. 2024 Dec 31;19(1):2319895. doi: 10.1080/19932820.2024.2319895. Epub 2024 Feb 23.
Lymphoblastic lymphoma.
Cortelazzo S, Ponzoni M, Ferreri AJ, Hoelzer D.
Crit Rev Oncol Hematol. 2011 Sep;79(3):330-43. doi: 10.1016/j.critrevonc.2010.12.003. Epub 2011 Jan 26.
Characterization of CD22 expression in acute lymphoblastic leukemia.
Shah NN, Stevenson MS, Yuan CM, Richards K, Delbrook C, Kreitman RJ, Pastan I, Wayne AS.
Pediatr Blood Cancer. 2015 Jun;62(6):964-9. doi: 10.1002/pbc.25410. Epub 2015 Mar 1.
CD99 in malignant hematopoiesis.
Ali A, Vaikari VP, Alachkar H.
Exp Hematol. 2022 Feb;106:40-46. doi: 10.1016/j.exphem.2021.12.363. Epub 2021 Dec 14.
PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia.
Xu X, Zhang W, Xuan L, Yu Y, Zheng W, Tao F, Nemechek J, He C, Ma W, Han X, Xie S, Zhao M, Wang J, Qu Y, Liu Q, Perry JM, Jiang L, Zhao M.
Nat Cell Biol. 2023 Jan;25(1):170-182. doi: 10.1038/s41556-022-01050-3. Epub 2023 Jan 9.
Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: Current Landscape in 2021.
Gauthier J, Turtle CJ.
Cancer J. 2021 Mar-Apr 01;27(2):98-106. doi: 10.1097/PPO.0000000000000508.
Significance of CD66c expression in childhood acute lymphoblastic leukemia.
Kiyokawa N, Iijima K, Tomita O, Miharu M, Hasegawa D, Kobayashi K, Okita H, Kajiwara M, Shimada H, Inukai T, Makimoto A, Fukushima T, Nanmoku T, Koh K, Manabe A, Kikuchi A, Sugita K, Fujimoto J, Hayashi Y, Ohara A.
Leuk Res. 2014 Jan;38(1):42-8. doi: 10.1016/j.leukres.2013.10.008. Epub 2013 Oct 22.
